Vol. 20 No. 6 (2022): Blood Transfusion - 6 2022 (November-December)
Editorial
Original article
-
The effectiveness of iron education through a mobile application on donor return after deferral for low hemoglobin
-
Transfusion-related acute lung injury (TRALI): a retrospective review of reported cases in Queensland, Australia over 20 years
-
Human neutrophil antigen 3 genotype impacts neutrophil-mediated endothelial cell cytotoxicity in a two-event model of TRALI
-
Effect of a Patient Blood Management system on perioperative transfusion practice and short-term outcomes of colorectal cancer surgery
-
3D analysis of CROMER (DAF) and a new antigen CRAG
-
Prevalence of ABO and RhD blood group phenotypes in the Croatian population and in patients with severe COVID-19 in Croatia
-
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19
-
Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism
-
Hepatitis E infection in adults with primary immunodeficiency with or without immunoglobulin replacement therapy
Letter to the Editor
-
Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure
-
COVID-19 vaccination, anticoagulation level and warfarin treatment
-
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more